LSI USA '23 filling fast. Register Now

New View Surgical | Bryce Klontz, CEO

Speakers

Bryce Klontz

Bryce Klontz

CEO, New View Surgical
New View Surgical, Inc. is an emerging medical device company developing proprietary imaging and access technologies for minimally invasive surgery.

Bryce Klontz  0:00  


I'm Bryce Klontz, CEO of New View Surgicalexcited to be back at our site give you guys an update on our technology. For those of you who do not know New View are a Boston based company developing novel and creative solutions in a surgical visualization space. And we've taken the mindset that today's visualization system and much of the equipment in the OR is complex. It's cumbersome, and it's expensive. And if we take a view towards simplification, miniaturization, and cost reduction, then we can truly create value across the value chain so it's rare that you look at clinical outcomes. Surgeon experience in the OR, OR staff perioperative time savings, reducing the stress of the perioperative teams before during and after surgery, and also have a conversation with administration about dramatic cost reduction in the surgical suite. So we've set our mission in place to address all of that value. And bring products to market that significantly address all of those issues in an effective way. So this is our first generation vision port product it's first in what will be a wide ranging portfolio with what we're creating. So we've taken a high end HD camera and placed it on the distal end of the access port. We've also built in inVivo lens cleaning lens washing and complete the fogging due to the proximity the LEDs to the camera. We've also built in a really innovative solution with mirrors and optical tip for optical entry. So we're not changing the surgeons technique when they're placing the device into the body. And what this design does at the system level is it dramatically reduces the capital and the Resterilizable capital to the boxes to control boxes and resterilizable capital that's used in the operating room every day, particularly to start out laparoscopic procedures, taking all that equipment and miniaturized it placed a vast majority of the technology into that camera module that's at the distal end of the access port, but also taking advantage of that modular miniaturized lower cost system and develop the two camera system which we believe can provide a lot of advantages in advanced surgery and even robotic surgery which I'll describe in just a moment. So this is a quick animation that shows the device the vision port is placed through the abdomen with the same technique as access ports are today. Using optical entry the operator is then removed and you see a two vision port scenario here. You've eliminated a port completely. You no longer have a laparoscope and a camera holder at the operating room table. The surgeons are complete control of the camera. And they can use a single vision port for a single port type surgery or use two cameras as as shown in this scenario to get two different angles for multi quadrant more complex surgery. So you see the animation wrapping up there. So we've moved from animation to the actual alarm correcting a lot of videos you can see in these scenarios. And we're not in humans yet. We're marching towards that later this year.

These are swine lab models and you can see surgeons operating autonomously. They're standing at the table and these scenarios I've got two cameras you can see the the image up there on the monitors and the surgeons are completing appendectomies, colles, gyn procedures, colorectal procedures bariatric procedures with this two camera system by reducing a port not having a camera holder there to communicate with and addressing all of the camera washing cleaning defogging scenarios without having to move the camera from the body. So a lot of very productive scenarios. This is a quick example and that's why models have a close discectomy and an appendectomy. Again, building off the images you just saw the surgeons are operating independently of their complete control of their camera. Now they're using a five port in addition to our single vision port in these scenarios. So with the funding that we raise, which we'll talk about just a moment, we are layering in software to continue to improve the image. And the system has all the capabilities that we want to continue to add in various features that are software driven anywhere from tissue tracking, to identification to or to incident tracking, tissue identification and the like. So we're pretty excited about this being a foundational platform that we can build on as we move into the future. So will this have an impact? So I talked about a simple idea of placing a camera on the end of an access port, and we very much believe it will and customers are coming along with us in that journey. This is recent research that we've done, which consistently shows that there are a lot of issues in the OR that still need dedicated effort to create value in whether it's inconsistent image quality from resterilized scopes, to staffing challenges that the hospitals and ORs are having today. Of course the escalating cost of equipment not only on original purchase of equipment, but sterilization, maintenance and repair as well as downtime and just that pressure to turn around cases in these ORs are all issues to address an ergonomics as well. We tend to talk about surgeons about desire to continue to improve our but ergonomics and as you saw those videos you saw the surgeons a very natural position with our camera systems able to operate. So this research was just completed. We continue to build on this as we move forward. But it really highlights the fact that while there are laparoscopic procedures done every day with great outcomes, there are still many challenges and we believe our simplified modular solution can can really make an impact there. We've been pleasantly surprised by the enthusiastic response that we get from economic side of that equation for working with surgeons developing that that clinical touch point we're talking a lot to the economic buyers, and they are enthusiastic in the idea of reducing cost per case taking down the stress of that perioperative time period moving equipment around having backup equipment and certainly impacting the initial clinical or initial capital purchase. That's a history in their budgets for years and certainly got a lot worse through the last couple years through the pandemic. So it's all about capturing value across this train and and again what I've shown you here technologyadvice we can offer value through surgeons to the patient from a clinical point of view, address the OR staff in the pain points at address there and have a real economic conversation with administration and really take this staff workflow and clinical outcome triple threat if you will and and talk value,  which we're very excited about. So a quick update from our presentation last year. We received 510K shortly after this meeting last year and in June we raised 9 million Series B off of that the monies of which we have today. And those funds are affording a transfer to manufacturing with a path to get us on the market for initial clinical cases late summer, early fall of this year, where this really exciting timeframe and the company are working through supply chain issues like everyone else's, but solving those fortunately and aiming for an initial market launch in a very controlled limited market release Yeah, late late summer, early fall. What we'll be doing in the market release is really working through the targeting strategy. We're very fortunate in this platform it can be used for any kind of procedure in the abdomen or in the in the chest. But with a early stage company with the funding will happen the focus will be focusing first on general surgery, GYN and colorectal surgery, colorectal surgery that two camera approach. Surgeons have found to be really productive, and I put in here amplify robotics. So this whole idea of using our technology for initial entry of robotic systems, but also this multi camera approach to gather visual data from multiple points of view without wheeling in an additional laproscopic tower, without creating an additional incision without having a second camera holder. We can provide visual data from multiple points of the operative field in addition to the robotic camera and drive that machine learning and AI and all that work that's ongoing. So we're really excited about that also be working on that which environment we enter first will certainly go to teaching hospitals where our device can complement teaching in a significant way. We believe our value is really gonna be generated in Community Hospital and rural hospitals that need that turnover time they're struggling with the staff, they don't have the camera holders, they don't have new capital equipment to keep the image quality where it needs to be and are struggling with those issues I showed earlier. So that's where value is gonna be really realized it will be balancing those different environments and driving data and early clinical results in each of those areas, working on environments, procedures, and ultimately driving towards understanding our model for scalability in 2023 as we commercialize and go to market. So with that, thank you for your time it's again excited to provide an update and I will be in the speaker room immediately thereafter, we would welcome anybody coming by and answering additional questions and getting to know what we're doing. So thank you for your time. I think it's time for lunch. Enjoy the rest of the conference and thank you.


Join us at the next LSI Emerging Medtech Summit

LSI's global events attract top innovators, active investors, and deal-making strategics.

GET INFO

Share this video

Our Clients